2023 PCE Oncology Fall Conferences - Solid Tumor Day

This complimentary CE/CME meeting is tailored to meet the clinical needs and evolving scope of practice for oncology NPs, PAs, and nurses. Review the latest evidence-based strategies for the contemporary care of your patients with breast cancer, gastric cancer, melanoma, and non-small-cell lung cancer via downloadable slides from CCO and PCE.

Share

Program Content

Activities

Combo IO-CT for Nurses
Combination Immunotherapy and Chemotherapy Regimens in NSCLC: Clinical Practice Recommendations for Oncology Nurses
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 28, 2023

Activities

High-Risk EBC
New Options in High-Risk Early Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 27, 2023

Targeted Therapy in EBC
My Experience Managing Key Adverse Events With Oral Targeted Therapy for High-Risk Early Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2023

PCE oncology fall 2023 BC
New Options in High-Risk Early Breast Cancer
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2023

Expires: December 10, 2024

Activities

Gastric Cancer
Maximizing Benefit With the Expanding Options for Gastric Cancer: Patient Selection and Management
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 27, 2023

PCE oncology fall 2023 GC
Maximizing Benefit With the Expanding Options for Gastric Cancer: Patient Selection and Management
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2023

Expires: December 10, 2024

Gastric Cancer: FAQs
Maximizing Benefit With the Expanding Options for Gastric Cancer: Expert Answers to Frequently Asked Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 22, 2023

Activities

Melanoma Adjuvant Immunotherapy
Driving Improved Outcomes in Resectable Melanoma: Pathways for Optimized Adjuvant Immunotherapy Strategies
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 28, 2023

Provided by

ProCE Banner
ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE) and Clinical Care Options, LLC

Supporters

Supported by educational grants from AstraZeneca; Bristol Myers Squibb; Merck Sharp & Dohme, LLC; and Regeneron Pharmaceuticals, Inc.

AstraZeneca

Bristol Myers Squibb

Merck Sharp & Dohme, LLC

Regeneron Pharmaceuticals, Inc

Partners

AIM at Melanoma Foundation

ProCE Banner